Prilocaine
- TRADE NAME: Citanest (AstraZeneca)
- INDICATIONS: Local anesthetic
- CLASS: Membrane integrity antagonist, Potassium channel antagonist, Sodium channel antagonist
- HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adenosine, Amide-type anesthetics, Antimalarials, Co-Trimoxazole, Dronedarone, Nitric compounds, Sulfonamides
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
HEMATOLOGIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
